Pinnacle Associates’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $247K | Buy |
860
+50
| +6% | +$14.4K | ﹤0.01% | 785 |
|
|
2025
Q1 | $250K | Hold |
810
| – | – | ﹤0.01% | 756 |
|
|
2024
Q4 | $286K | Buy |
+810
| New | +$286K | ﹤0.01% | 729 |
|
|
2024
Q3 | – | Sell |
-910
| Closed | -$290K | – | 851 |
|
|
2024
Q2 | $290K | Sell |
910
-50
| -5% | -$15.9K | ﹤0.01% | 695 |
|
|
2024
Q1 | $221K | Buy |
+960
| New | +$221K | ﹤0.01% | 778 |
|
|
2018
Q1 | – | Sell |
-2,915
| Closed | -$431K | – | 713 |
|
|
2017
Q4 | $431K | Sell |
2,915
-1,060
| -27% | -$157K | 0.01% | 518 |
|
|
2017
Q3 | $466K | Sell |
3,975
-140
| -3% | -$16.4K | 0.01% | 503 |
|
|
2017
Q2 | $534K | Sell |
4,115
-755
| -16% | -$98K | 0.01% | 495 |
|
|
2017
Q1 | $659K | Sell |
4,870
-9,309
| -66% | -$1.26M | 0.01% | 460 |
|
|
2016
Q4 | $2.03M | Sell |
14,179
-670
| -5% | -$96.1K | 0.04% | 303 |
|
|
2016
Q3 | $1.75M | Sell |
14,849
-8,868
| -37% | -$1.05M | 0.04% | 317 |
|
|
2016
Q2 | $2.51M | Sell |
23,717
-18,723
| -44% | -$1.98M | 0.05% | 272 |
|
|
2016
Q1 | $4.73M | Buy |
42,440
+30
| +0.1% | +$3.34K | 0.1% | 203 |
|
|
2015
Q4 | $6.64M | Sell |
42,410
-1,435
| -3% | -$225K | 0.14% | 158 |
|
|
2015
Q3 | $5.75M | Sell |
43,845
-1,376
| -3% | -$181K | 0.13% | 171 |
|
|
2015
Q2 | $7.87M | Sell |
45,221
-3,215
| -7% | -$559K | 0.15% | 149 |
|
|
2015
Q1 | $8.35M | Buy |
+48,436
| New | +$8.35M | 0.16% | 145 |
|